GastroMARK

Company: Advanced Magnetics
Approval Status: Approved May 1996
Treatment for: gastrointestinal forms of cancer
Areas: Gastrointestinal; Cancer & Oncology

| General Information |

General Information

GastroMARK has been approved as a magnetic resonance imaging agent for the gastrointestinal tract. Administered orally, GastroMark enhances the contrast between the bowel and other abdominal structures and masses in MRI images.

< back to top

GastroMARK Drug Information

The Gastromark drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.